HudsonAlpha Welcomes New Vice President for Translational Health Science, Jennifer Lovejoy
September 02, 2026
September 02, 2026
HUNTSVILLE, Alabama, Sept. 2 -- The HudsonAlpha Institute for Biotechnology issued the following news:
* * *
HudsonAlpha Welcomes New Vice President for Translational Health Science, Jennifer Lovejoy
Lovejoy will lead HOPE AD and related multi omic, longitudinal, and intervention-based programs focused on chronic disease prevention and precision health.
-
The HudsonAlpha Institute for Biotechnology recently welcomed Jennifer Lovejo . . .
* * *
HudsonAlpha Welcomes New Vice President for Translational Health Science, Jennifer Lovejoy
Lovejoy will lead HOPE AD and related multi omic, longitudinal, and intervention-based programs focused on chronic disease prevention and precision health.
-
The HudsonAlpha Institute for Biotechnology recently welcomed Jennifer Lovejo . . .
